Herbs (Global Traditional) · Traditional Chinese Medicine
Goldthread (Coptis chinensis) (Coptis chinensis)
Moderate Evidencebotanical
Hermetica Superfood Encyclopedia
Goldthread (Coptis chinensis) is a Traditional Chinese Medicine herb containing high concentrations of berberine alkaloids, with extracts yielding up to 45.4 mg/g berberine. The herb's bioactive isoquinoline alkaloids including berberine, coptisine, and palmatine have been studied for antimicrobial and metabolic effects.
Coptis chinensis, commonly known as goldthread or Chinese goldthread, is a perennial herb native to China belonging to the Ranunculaceae family, with its rhizomes used medicinally. The rhizomes are typically extracted using methods like whole-herb percolation with vegetable glycerine, alcohol, and water (1:3 ratio), ultrasound-assisted extraction with acids, or microwave-assisted extraction to yield isoquinoline alkaloids.
No human clinical trials, randomized controlled trials (RCTs), or meta-analyses for Coptis chinensis were found in the available research. The current evidence is limited to extraction optimization studies and chemical characterization of alkaloid content.
No clinically studied dosage ranges are available as no human clinical trials have been documented. Extraction studies optimize for alkaloid yield but do not specify therapeutic dosing. Consult a healthcare provider before starting any new supplement.
Goldthread (Coptis chinensis) is not consumed as a food source and therefore lacks a conventional macronutrient profile (negligible protein, fat, carbohydrate, and fiber per typical medicinal dose of 1.5–12 g dried rhizome). Its significance lies entirely in its bioactive alkaloid and phytochemical content. **Primary alkaloids (isoquinoline class):** Berberine is the dominant compound at approximately 5–9% of dried rhizome weight (50–90 mg/g; up to 45.4 mg/g in standardized aqueous extracts), followed by coptisine (~1.5–3.5% dry weight), palmatine (~0.5–2.5% dry weight), jatrorrhizine (~0.5–1.5% dry weight), and epiberberine (~0.3–1.0% dry weight). Total alkaloid content can reach 10–15% of dried rhizome. **Secondary bioactive compounds:** Ferulic acid, magnoflorine (aporphine alkaloid), worenine, columbamine, and trace lignans. **Phenolic/flavonoid compounds:** Quercetin and chlorogenic acid are present in minor quantities (exact concentrations variable by extraction method). Total phenolic content of ethanolic extracts has been reported at approximately 146.3 mg gallic acid equivalents per gram of extract. **Minerals:** Trace amounts of potassium, calcium, magnesium, iron, zinc, and manganese are present in the rhizome but are not nutritionally significant at medicinal doses. **Bioavailability notes:** Berberine has notoriously poor oral bioavailability (estimated <5% in humans) due to extensive first-pass metabolism by CYP enzymes and P-glycoprotein efflux in the intestinal wall. Gut microbiota may convert berberine to dihydroberberine, which has higher intestinal absorption and is re-oxidized back to berberine in tissues. Coptisine and palmatine share similarly low oral bioavailability profiles. The alkaloids are water-soluble salts (typically chloride or sulfate forms in the plant), making them extractable in traditional decoctions, though absorption remains limited. Co-administration with P-glycoprotein inhibitors or lipid-based delivery systems may enhance bioavailability.
Goldthread's primary bioactive compound berberine activates AMP-activated protein kinase (AMPK) pathways and inhibits bacterial DNA gyrase. Coptisine and palmatine alkaloids demonstrate antimicrobial activity through cell membrane disruption and interference with bacterial protein synthesis. These isoquinoline alkaloids also modulate glucose metabolism by enhancing insulin sensitivity.
Current evidence for goldthread is limited to preclinical studies and traditional use documentation. Laboratory studies have isolated and quantified berberine concentrations up to 45.4 mg/g in standardized extracts. In vitro antimicrobial studies show activity against various bacterial strains, but human clinical trials are lacking. The herb remains classified as traditional medicine with insufficient clinical evidence for specific health claims.
Goldthread safety profile in humans is not well-established through clinical studies. Berberine-containing herbs may interact with diabetes medications by enhancing hypoglycemic effects. Potential gastrointestinal side effects including nausea and diarrhea have been reported with berberine supplements. Pregnancy and breastfeeding safety data is insufficient, and the herb may interact with cytochrome P450 enzymes affecting drug metabolism.
